Vulnerability for ventricular arrhythmias in patients with chronic coronary total occlusion

References

• Azzalini L, Jolicoeur EM, Pighi M, et al. Epidemiology, management strategies, and outcomes of patients with chronic total coronary occlusion. Am J Cardiol. 2016;118(8):1128–1135.
   PubMed Web of Science ®Google Scholar
• Redfors B, Ramunddal T, Angeras O, et al. Angiographic findings and survival in patients undergoing coronary angiography due to sudden cardiac arrest in western Sweden. Resuscitation. 2015;90:13–20.
   PubMed Web of Science ®Google Scholar
• Nishiyama K, Shizuta S, Doi T, et al. Sudden cardiac death after PCI and CABG in the bare-metal stent era: incidence, prevalence, and predictors. Int J Cardiol. 2010;144(2):263–266.
   PubMed Web of Science ®Google Scholar
• Arslan U, Balcioglu AS, Timurkaynak T, et al. The clinical outcomes of percutaneous coronary intervention in chronic total coronary occlusion. Int Heart J. 2006;47(6):811–819.
   PubMed Web of Science ®Google Scholar
• Nombela-Franco L, Iannaccone M, Anguera I, et al., Impact of chronic total coronary occlusion on recurrence of ventricular arrhythmias in ischemic secondary prevention implantable cardioverter-defibrillator recipients (VACTO secondary study): insights from coronary angiogram and electrogram analysis. JACC Cardiovasc Interventions. 10(9): 879–888. 2017.
   PubMed Web of Science ®Google Scholar
• Nombela-Franco L, Mitroi CD, Fernandez-Lozano I, et al., Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study). Circ Arrhythm Electrophysiol. 5(1): 147–154. 2012.
   PubMed Web of Science ®Google Scholar
• Yap SC, Sakhi R, Theuns D, et al., Increased risk of ventricular arrhythmias in survivors of out-of-hospital cardiac arrest with chronic total coronary occlusion. Heart Rhythm. 15(1): 124–129. 2018.
   PubMed Web of Science ®Google Scholar
• Chi WK, Gong M, Bazoukis G, et al., Impact of coronary artery chronic total occlusion on arrhythmic and mortality outcomes: a systematic review and meta-analysis. JACC Clin Electrophysiol. 4(9): 1214–1223. 2018.
   PubMedGoogle Scholar
• Di Marco A, Anguera I, Teruel L, et al., Chronic total occlusion of an infarct-related artery: a new predictor of ventricular arrhythmias in primary prevention implantable cardioverter defibrillator patients. Europace. 19(2): 267–274. 2017.
   PubMed Web of Science ®Google Scholar
• Di Marco A, Anguera I, Teruel L, et al. Chronic total occlusion in an infarct-related coronary artery and the risk of appropriate ICD therapies. J Cardiovasc Electrophysiol. 2017;28(10):1169–1178.
   PubMed Web of Science ®Google Scholar
• Di Marco A, Paglino G, Oloriz T, et al. Impact of a chronic total occlusion in an infarct-related artery on the long-term outcome of ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2015;26(5):532–539.
   PubMed Web of Science ®Google Scholar
• Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian multicenter chronic total occlusions registry. J Am Coll Cardiol. 2012;59(11):991–997.
   PubMed Web of Science ®Google Scholar
• Ramunddal T, Hoebers LP, Henriques JP, et al. Chronic total occlusions in Sweden–a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). PLoS One. 2014;9(8):e103850.
   PubMed Web of Science ®Google Scholar
• Tomasello SD, Boukhris M, Giubilato S, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J. 2015;36(45):3189–3198.
   PubMed Web of Science ®Google Scholar
• Jeroudi OM, Alomar ME, Michael TT, et al. Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital. Catheter Cardiovasc Interv. 2014;84(4):637–643.
   PubMed Web of Science ®Google Scholar
• Lee SW, Lee PH, Ahn JM, et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion. Circulation. 2019;139(14):1674–1683.
   PubMed Web of Science ®Google Scholar
• Safley DM, Grantham JA, Hatch J, et al. Quality of life benefits of percutaneous coronary intervention for chronic occlusions. Catheter Cardiovasc Interv. 2014;84(4):629–634.
   PubMed Web of Science ®Google Scholar
• Safley DM, Koshy S, Grantham JA, et al. Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. Catheter Cardiovasc Interv. 2011;78(3):337–343.
   PubMed Web of Science ®Google Scholar
• Rossello X, Pujadas S, Serra A, et al. Assessment of inducible myocardial ischemia, quality of life, and functional status after successful percutaneous revascularization in patients with chronic total coronary occlusion. Am J Cardiol. 2016;117(5):720–726.
   PubMed Web of Science ®Google Scholar
• Azzalini L, Vo M, Dens J, et al. Myths to debunk to improve management, referral, and outcomes in patients with chronic total occlusion of an epicardial coronary artery. Am J Cardiol. 2015;116(11):1774–1780.
   PubMed Web of Science ®Google Scholar
• Jang WJ, Yang JH, Choi SH, et al. Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation. JACC Cardiovasc Interv. 2015;8(2):271–279.
   PubMed Web of Science ®Google Scholar
• Christakopoulos GE, Christopoulos G, Carlino M, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2015;115(10):1367–1375.
   PubMed Web of Science ®Google Scholar
• Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. Am Heart J. 2010;160(1):179–187.
   PubMed Web of Science ®Google Scholar
• Lee NH, Cho YH, Seo HS. Successful recanalization of in-stent coronary chronic total occlusion by subintimal tracking. J Invasive Cardiol. 2008;20(4):E129–32.
   PubMedGoogle Scholar
• Henriques JP, Hoebers LP, Ramunddal T, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. J Am Coll Cardiol. 2016;68(15):1622–1632.
   PubMed Web of Science ®Google Scholar
• Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018;39(26):2484–2493.
   PubMed Web of Science ®Google Scholar
• Obedinskiy AA, Kretov EI, Boukhris M, et al. The IMPACTOR-CTO Trial. JACC Cardiovasc Interv. 2018;11(13):1309–1311.
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm. 2018;15(10):e73–e189.
   PubMed Web of Science ®Google Scholar
• Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793–2867.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200.
   PubMed Web of Science ®Google Scholar
• Raja V, Wiegn P, Obel O, et al. Impact of chronic total occlusions and coronary revascularization on all-cause mortality and the incidence of ventricular arrhythmias in patients with ischemic cardiomyopathy. Am J Cardiol. 2015;116(9):1358–1362.
   PubMed Web of Science ®Google Scholar
• van Dongen IM, Yilmaz D, Elias J, et al. Evaluation of the impact of a chronic total coronary occlusion on ventricular arrhythmias and long-term mortality in patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (the eCTOpy-in-ICD Study). J Am Heart Assoc. 2018;7(10). doi:10.1161/JAHA.118.008609.
   PubMed Web of Science ®Google Scholar
• Wang ZQ, Qiang H, Luo X, et al. Meta-analysis of risk of ventricular arrhythmias and all-cause mortality in patients with chronic total occlusion of a coronary artery and/or implantable cardioverter-defibrillator. Am J Cardiol. 2018;121(10):1149–1154.
   PubMed Web of Science ®Google Scholar
• Horowitz LN, Josephson ME, Harken AH. Epicardial and endocardial activation during sustained ventricular tachycardia in man. Circulation. 1980;61(6):1227–1238.
   PubMed Web of Science ®Google Scholar
• de Bakker JM, Coronel R, Tasseron S, et al. Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol. 1990;15(7):1594–1607.
   PubMed Web of Science ®Google Scholar
• de Bakker JM, van Capelle FJ, Janse MJ, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988;77(3):589–606.
   PubMed Web of Science ®Google Scholar
• Roes SD, Borleffs CJ, van der Geest RJ, et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging. 2009;2(3):183–190.
   PubMed Web of Science ®Google Scholar
• Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115(15):2006–2014.
   PubMed Web of Science ®Google Scholar
• de Haan S, Meijers TA, Knaapen P, et al. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models. Heart. 2011;97(23):1951–1956.
   PubMed Web of Science ®Google Scholar
• van Dongen IM, Elias J, Meijborg VMF, et al., Electrocardiographic changes after successful recanalization of a chronic total coronary occlusion. A systematic review and meta-analysis. Cardiovasc Revasc Med. 19(2): 221–228. 2018.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Igawa W, Ono M, et al., Impact of recanalization of chronic total occlusion on left ventricular electrical remodeling. Pacing Clin Electrophysiol. 42(6): 712–721. 2019.
   PubMed Web of Science ®Google Scholar
• Swann MH, Nakagawa H, Vanoli E, et al. Heterogeneous regional endocardial repolarization is associated with increased risk for ischemia-dependent ventricular fibrillation after myocardial infarction. J Cardiovasc Electrophysiol. 2003;14(8):873–879.
   PubMed Web of Science ®Google Scholar
• Werner GS. The role of coronary collaterals in chronic total occlusions. Curr Cardiol Rev. 2014;10(1):57–64.
   PubMedGoogle Scholar
• Werner GS, Surber R, Ferrari M, et al. The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J. 2006;27(20):2406–2412.
   PubMed Web of Science ®Google Scholar
• Sachdeva R, Agrawal M, Flynn SE, et al., The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv. 83(1): 9–16. 2014.
   PubMed Web of Science ®Google Scholar
• Opthof T, Coronel R, Vermeulen JT, et al. Dispersion of refractoriness in normal and ischaemic canine ventricle: effects of sympathetic stimulation. Cardiovasc Res. 1993;27(11):1954–1960.
   PubMed Web of Science ®Google Scholar
• Ripley DP, Gosling OE, Bhatia L, et al. The relationship between the contralateral collateral supply and myocardial viability on cardiovascular magnetic resonance: can the angiogram predict functional recovery? Int J Cardiol. 2014;177(2):362–367.
   PubMed Web of Science ®Google Scholar
• Elias J, van Dongen IM, Hoebers LP, et al. Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trial. J Cardiovasc Magn Reson. 2017;19(1):53.
   PubMedGoogle Scholar
• Canty JM Jr., Suzuki G, Banas MD, et al. Hibernating myocardium: chronically adapted to ischemia but vulnerable to sudden death. Circ Res. 2004;94(8):1142–1149.
   PubMed Web of Science ®Google Scholar
• Lim H, Fallavollita JA, Hard R, et al. Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium. Circulation. 1999;100(23):2380–2386.
   PubMed Web of Science ®Google Scholar
• Fallavollita JA, Perry BJ, Canty JM Jr. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation. 1997;95(7):1900–1909.
   PubMed Web of Science ®Google Scholar
• Luisi AJ Jr., Fallavollita JA, Suzuki G, et al. Spatial inhomogeneity of sympathetic nerve function in hibernating myocardium. Circulation. 2002;106(7):779–781.
   PubMed Web of Science ®Google Scholar
• Kouvas N, Kontogiannis C, Georgiopoulos G, et al. The complex crosstalk between inflammatory cytokines and ventricular arrhythmias. Cytokine. 2018;111:171–177.
   PubMed Web of Science ®Google Scholar
• Yang KC, Kyle JW, Makielski JC, et al. Mechanisms of sudden cardiac death: oxidants and metabolism. Circ Res. 2015;116(12):1937–1955.
   PubMed Web of Science ®Google Scholar
• Li KHC, Wong KHG, Gong M, et al. Percutaneous coronary intervention versus medical therapy for chronic total occlusion of coronary arteries: a systematic review and meta-analysis. Curr Atheroscler Rep. 2019;21(10):42.
   PubMed Web of Science ®Google Scholar
• Godino C, Giannattasio A, Scotti A, et al., Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion. Heart. 105(14): 1096–1102. 2019.
   PubMed Web of Science ®Google Scholar
• Hoebers LP, Claessen BE, Elias J, et al. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol. 2015;187:90–96.
   PubMed Web of Science ®Google Scholar
• van Dongen IM, Kolk MZH, Elias J, et al. The effect of revascularization of a chronic total coronary occlusion on electrocardiographic variables. A sub-study of the EXPLORE trial. J Electrocardiol. 2018;51(5):906–912.
   PubMed Web of Science ®Google Scholar
• Pristipino C, Granatelli A, Capasso M, et al. Effects of reperfusion obtained two to six months after acute myocardial infarction on myocardial electrical stabilization in patients with an occluded infarct-related coronary artery. Am J Cardiol. 2005;96(6):769–772.
   PubMed Web of Science ®Google Scholar
• Cetin M, Zencir C, Cakici M, et al. Effect of a successful percutaneous coronary intervention for chronic total occlusion on parameters of ventricular repolarization. Coron Artery Dis. 2014;25(8):705–712.
   PubMed Web of Science ®Google Scholar
• Myat A, Patel M, Silberbauer J, et al. Chronic total coronary occlusion revascularisation positively modifies infarct-related myocardial scar responsible for recurrent ventricular tachycardia. EuroIntervention. 2019. Published online 2019 Jul 2.
   PubMed Web of Science ®Google Scholar
• Baumert M. Measurement of T wave variability in body surface ECG. J Electrocardiol. 2016;49(6):883–886.
   PubMed Web of Science ®Google Scholar
• Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter unsustained tachycardia trial investigators. N Engl J Med. 2000;342(26):1937–1945.
   PubMedGoogle Scholar
• Korhonen P, Husa T, Konttila T, et al. Complex T-wave morphology in body surface potential mapping in prediction of arrhythmic events in patients with acute myocardial infarction and cardiac dysfunction. Europace. 2009;11(4):514–520.
   PubMed Web of Science ®Google Scholar
• Fereniec M, Stix G, Kania M, et al. Risk assessment of ventricular arrhythmia using new parameters based on high resolution body surface potential mapping. Med Sci Monit. 2011;17(3):MT26–33.
   PubMed Web of Science ®Google Scholar
• Fereniec M, Stix G, Kania M, et al. An analysis of the U-wave and its relation to the T-wave in body surface potential maps for healthy subjects and MI patients. Ann Noninvasive Electrocardiol. 2014;19(2):145–156.
   PubMed Web of Science ®Google Scholar